Traditionally, developing treatments for rare conditions has been challenging due to high costs and limited research.
AI’s ability to analyze vast datasets and identify potential drug-disease relationships has revolutionized the approach toward drug discovery, especially for rare diseases. Traditionally, developing treatments for rare conditions has been challenging due to high costs and limited research. However, AI’s intervention in this process has opened new doors, offering more efficient and cost-effective solutions.